|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Provision for transaction losses | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other income, net | |||||
| Income before income taxes | |||||
| Income tax (provision) benefit | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares used to compute net income per share, basic and diluted | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other comprehensive income, net of tax: | |||||
| Net unrealized holding gain on marketable securities, net | |||||
| Total comprehensive income | |||||
Loading...